Similar articles for PMID: 15688371

Year	Number of Results
1990	1
1993	3
1994	2
1995	6
1996	15
1997	11
1998	14
1999	12
2000	17
2001	17
2002	22
2003	14
2004	15
2005	14
2006	11
2007	8
2008	8
2009	11
2010	9
2011	6
2012	9
2013	3
2014	4
2015	2
2016	6
2017	3
2018	3
2019	2
2020	3
2021	3
2022	2
2023	1
2024	0

1

Differences in phenotype and function between spontaneously occurring melan-A-, tyrosinase- and influenza matrix peptide-specific CTL in HLA-A*0201 melanoma patients.

Maczek C, Berger TG, Schuler-Thurner B, Schultz ES, Hamann A, Dunbar PR, Cerundolo V, Steinkasserer A, Schuler G. Maczek C, et al. Int J Cancer. 2005 Jun 20;115(3):450-5. doi: 10.1002/ijc.20901. Int J Cancer. 2005. PMID: 15688371 Free article.

2

Selective responsiveness to common gamma chain cytokines in peripheral blood-derived cytotoxic T lymphocytes induced by Melan-A/MART-1(27-35)targeted active specific immunotherapy.

von Holzen U, Adamina M, Bolli M, Weber WP, Zajac P, Groeper C, Reschner A, Feder C, Schumacher R, Marti W, Oertli D, Heberer M, Spagnoli GC. von Holzen U, et al. Int J Cancer. 2005 Jun 10;115(2):248-55. doi: 10.1002/ijc.20858. Int J Cancer. 2005. PMID: 15688403 Free article.

3

A shift in the phenotype of melan-A-specific CTL identifies melanoma patients with an active tumor-specific immune response.

Dunbar PR, Smith CL, Chao D, Salio M, Shepherd D, Mirza F, Lipp M, Lanzavecchia A, Sallusto F, Evans A, Russell-Jones R, Harris AL, Cerundolo V. Dunbar PR, et al. J Immunol. 2000 Dec 1;165(11):6644-52. doi: 10.4049/jimmunol.165.11.6644. J Immunol. 2000. PMID: 11086110

4

Novel approach to the characterization of melanoma associated-peptide-specific CTL lines from Japanese metastatic melanoma patients.

Akiyama Y, Maruyama K, Tai S, Takikawa M, Ohshita C, Yamamoto A, Yamazaki N, Kiyohara Y, Yamaguchi K. Akiyama Y, et al. Int J Oncol. 2008 Sep;33(3):433-41. Int J Oncol. 2008. PMID: 18695871

5

Enhanced generation of specific tumor-reactive CTL in vitro by selected Melan-A/MART-1 immunodominant peptide analogues.

Valmori D, Fonteneau JF, Lizana CM, Gervois N, Liénard D, Rimoldi D, Jongeneel V, Jotereau F, Cerottini JC, Romero P. Valmori D, et al. J Immunol. 1998 Feb 15;160(4):1750-8. J Immunol. 1998. PMID: 9469433

6

Novel soluble HLA-A2/MELAN-A complexes selectively stain a differentiation defective subpopulation of CD8+ T cells in patients with melanoma.

Guillaume P, Baumgaertner P, Neff L, Rufer N, Wettstein P, Speiser DE, Luescher IF. Guillaume P, et al. Int J Cancer. 2010 Aug 15;127(4):910-23. doi: 10.1002/ijc.25099. Int J Cancer. 2010. PMID: 19998338 Free article.

7

Peptide-specific CTL in tumor infiltrating lymphocytes from metastatic melanomas expressing MART-1/Melan-A, gp100 and Tyrosinase genes: a study in an unselected group of HLA-A2.1-positive patients.

Spagnoli GC, Schaefer C, Willimann TE, Kocher T, Amoroso A, Juretic A, Zuber M, Luscher U, Harder F, Heberer M. Spagnoli GC, et al. Int J Cancer. 1995 Oct 20;64(5):309-15. doi: 10.1002/ijc.2910640505. Int J Cancer. 1995. PMID: 7591302

8

Analysis of T-cell responses in metastatic melanoma patients vaccinated with dendritic cells pulsed with tumor lysates.

Griffioen M, Borghi M, Schrier PI, Osanto S, Schadendorf D. Griffioen M, et al. Cancer Immunol Immunother. 2004 Aug;53(8):715-22. doi: 10.1007/s00262-004-0514-z. Epub 2004 Mar 3. Cancer Immunol Immunother. 2004. PMID: 14997347

9

Lack of terminally differentiated tumor-specific CD8+ T cells at tumor site in spite of antitumor immunity to self-antigens in human metastatic melanoma.

Mortarini R, Piris A, Maurichi A, Molla A, Bersani I, Bono A, Bartoli C, Santinami M, Lombardo C, Ravagnani F, Cascinelli N, Parmiani G, Anichini A. Mortarini R, et al. Cancer Res. 2003 May 15;63(10):2535-45. Cancer Res. 2003. PMID: 12750277

10

Circulating Melan-A/Mart-1 specific cytolytic T lymphocyte precursors in HLA-A2+ melanoma patients have a memory phenotype.

D'Souza S, Rimoldi D, Líenard D, Lejeune F, Cerottini JC, Romero P. D'Souza S, et al. Int J Cancer. 1998 Dec 9;78(6):699-706. doi: 10.1002/(sici)1097-0215(19981209)78:6<699::aid-ijc6>3.0.co;2-u. Int J Cancer. 1998. PMID: 9833762 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

246 results

Results by year